FDA Clearance Tracker · P160054-S007
HeartMate 3 Left Ventricular Assist System (LVAS)
Last checked: Nov 20, 2026Latest source record: Jul 5, 2018 (this decision)Source: openFDAMethods & limitations
Decided
Jul 5, 2018
Approved
Time to decision
80 days
Received Apr 16, 2018. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track
Device class
Class III
The decision
- FDA number
- P160054-S007
- Device name
- HeartMate 3 Left Ventricular Assist System (LVAS)
- Applicant
- ABBOTT MEDICAL
- Applicant location
- Pleasanton, CA
- Received
- Apr 16, 2018
- Decided
- Jul 5, 2018
- Decision
- Approved
- Supplement type
- Normal 180 Day Track
- Reason for supplement
- Change Design/Components/Specifications/Material
- Original approval
- P160054
Device type
- Device type
- Ventricular (assist) bypass (DSQ)
- Device class
- Class III
- Specialty
- Cardiology
FDA's approval statement
As written in FDA's record.
Approval for introducing: 1) various design modifications to the Tunneling Adapter and Tunneling Lance; 2) various design modifications to the HeartMate 3 LVAD inner tray; and 3) a standalone packaging configuration for the modified Tunneling Adapter, with a shelf life of 3 years.
Source documents
Other decisions for ABBOTT MEDICAL
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
P260019 · Decided Oct 27, 2026 · 180 days after receipt
Device type: Para-device leak occluder (SJT) · Cardiology
7 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.